Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Etoposide-platinum (EP) chemotherapy has long stood as the reference treatment of grade 3 neuroendocrine neoplasms (G3 NEN). However, G3 NEN are heterogeneous, including well differentiated tumours (NET) and poorly differentiated carcinomas of large (LCNEC) or small (SCNEC) cell type, whose identification can be challenging and response to EP be very variable, usually low in NET.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Lacombe C, De Rycke O, Chen R, Colnot N, Hentic O,
Keywords: grade 3, chemotherapy, biomarkers, etoposide-platinum, pRb, p53,
#2133 Clinicopathological Features of the High Grade Pancreatic Neuroendocrine Neoplasms
Introduction: The high grade pancreatic neuroendocrine neoplasms (PanNENs) include well-differentiated tumors (WD-NETs) with elevated proliferation and poorly differentiated carcinomas (PD-NECs).
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Delektorskaya V, Solovieva O, Koslov N, Patyutko Y,
Keywords: neuroendocrine, pancreas, neoplasm, grade, survival,
Introduction: The WHO 2010 classification has provided a valuable tool to stratify NEN prognosis based on an objective measure, the proliferation index. However, morphology and, in particular, tumor differentiation, is emerging again as a relevant feature that should not be dismissed due to its important clinical implications.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: García Carbonero R
Authors: Sánchez Cánovas M, Nuñez B, Benavent M, Teulé A, Segura A,
Keywords: WHO 2010 classification,
Introduction: Aggressive neuroendocrine neoplasms (NEN) encompass both poorly differentiated carcinomas (NEC) and high grade neuroendocrine tumors (G3-NET) with a Ki-67 index >20%; WHO 2010.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: olsen i
Authors: Olsen I, Borbath I, Heetfeld M, Walter T, Barriuso J,
Keywords: neuroendocrine carcinoma, Ki-67, immunohistochemistry, treatment,
Introduction: Neuroendocrine neoplasms (NENs) with a Ki-67 >20% (Grade 3) are classified together as Neuroendocrine Carcinomas (NEC), and are usually considered as poorly differentiated. However Grade (G)3 NENs may be heterogeneous, with some demonstrating a well-differentiated cell morphology.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Mandair D, O'Leary J, Luong T, Thirlwell C, Meyer T,